July 5, 2005

   

 

IMAGING
Aetna Issues New Reimbursement Policy

QUALITY IMPROVEMENT
AMA Adopts Pay-for-Performance Guidelines

MEDICAL LIABILITY REFORM
Connecticut Governor Signals Willingness to Sign Liability Law

LEGISLATIVE/REGULATORY
Medicare Pay-for-Performance Bill Unveiled
House Approves FY 2006 Labor-HHS Appropriations Billg
Drug Tracking Bill Moves Forward
FDA Panel Rejects Artificial Heart
IMAGING

Aetna Issues New Reimbursement Policy
As of June 15, Aetna will reimburse each of the add-on codes wall motion study (78478) and ejection fraction (78480 ) when billed with a myocardial perfusion imaging study (78460-78465). Aetna recently sent an update in its provider newsletter explaining the new reimbursement policy.

ACC has confirmed with Susan Millerick and Stacie Watson, Aetna’s spokesperson and Head of Clinical and Reimbursement Policy Administration, respectively, that the system change will allow reconsideration (retroactive reimbursement) of claims, based on the May 14 implementation date, for 180 days (six months) from the date of the initial claim determination (Aetna’s date) provided that the claim was submitted within the timely filing limits, or 60 days for an appeal if reconsideration has previously occurred, provided appeal rights still exist for the claim. For more information, contact Mia Thomas of Payer Advocacy at 301-581-3418.

QUALITY IMPROVEMENT

AMA Adopts Pay-for-Performance Guidelines
The American Medical Association (AMA) House of Delegates has adopted comprehensive guidelines for pay-for-performance programs. The guidelines cover quality of care; the patient/physician relationship; physician participation; physician data and reporting; and program rewards. While the AMA has tried to forge consensus among the physician community on a core set of guidelines and principles, a number of surgical societies concerned about the Congress’ interest in moving to a pay-for-performance system as early as 2008 amended the resolution so it states that the AMA oppose any pay-for-performance programs unless they meet the guidelines and principles. Some groups, including the ACC and the American College of Physicians (ACP), are concerned about the hard line that effectively has been drawn by requiring that all the principles and guidelines be met. “This is going to make it very difficult for the AMA to engage constructively in influencing what comes out of Medicare,” said Robert Doherty, senior vice president of ACP.

MEDICAL LIABILITY REFORM
Connecticut Governor Signals Willingness to Sign Liability Law
Connecticut Gov. M. Jodi Rell, R, has said she is “inclined to sign” a bill adopted by the state legislature that would require the state insurance department to approve malpractice insurance premium rates of 7.5 percent or higher. The measure also limits attorney fees in malpractice cases and reduces interest rates on malpractice settlements paid over time.  
LEGISLATIVE/REGULATORY

Medicare Pay-for-Performance Bill Unveiled
Senate Finance Committee Chairman Charles Grassley, R-IA, and the committee’s ranking Democrat, Senator Max Baucus, MT, have introduced a bill to encourage reporting of quality data. The legislation would allow the secretary of the Department of Health and Human Services (HHS) to first reward providers when they report quality data and then, again, when they achieve quality improvements. The bill would also authorize a national healthcare information technology pilot program. The ACC is currently reviewing the legislation.

House Approves FY 2006 Labor-HHS Appropriations Bill
The House of Representatives voted 250-151 to pass the $602 billion Labor-Health and Human Services-Education appropriations bill for fiscal year 2006. The measure, adopted June 24, funds the Medicare and Medicaid programs and includes monies to implement the new Medicare prescription drug program. Funding for the National Institutes of Health is slated at $28.5 billion, a half-percent increase from the current year. Prior to passage, the House rejected an amendment that would have prohibited the use of appropriated funds for the distribution of personal Medicare and Medicaid beneficiary information to private companies for marketing purposes. A Senate subcommittee will take up its version of the funding measure after the July 4 congressional recess.
 
Drug Tracking Bill Moves Forward
The House Energy and Commerce Subcommittee on Health has marked up legislation (H.R. 1132) to provide grants to states to establish a uniform electronic database system to enable physicians and pharmacists to flag drug interactions. The measure would also allow providers to track patients who abuse prescription drugs. The Senate Health, Education, Labor and Pensions Committee has approved similar legislation.
FDA Panel Rejects Artificial Heart
A Food and Drug Administration (FDA) advisory panel has recommended, 7-6, that the agency reject a request by Abiomed to sell the AbioCor artificial heart. The panel found that most recipients of the fully implantable artificial heart had suffered serious side effects.  
Questions? Comments? Send your feedback to epubs@acc.org and include the name of the publication in the subject line.
Back to Top | | Copyright © 2008 American College of Cardiology
Heart House | 2400 N Street, NW | Washington, DC 20037